Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

S-100 beta positive T cell leukemia.

K Takahashi1, Y Ohtsuki, H Sonobe

  • 1Department of Pathology, Kochi Medical School, Nankoku, Japan.

Blood
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bullous pemphigoid suggestive of complement-independent blister formation with anti-BP180 IgG4 autoantibodies.

The British journal of dermatology·2016
Same author

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.

Oncogene·2013
Same author

S-100 protein-positive dendritic cells detected in hepatocellular-carcinoma in relation to tumor progression and prognosis.

International journal of oncology·2011
Same author

The aberrant p53 protein (review).

International journal of oncology·2011
Same author

Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2011
Same author

Secondary-phase-modulation method for open-loop fiber-optic gyroscopes.

Applied optics·2010

This study reports a rare case of S-100 beta positive T cell leukemia in a 34-year-old woman. This aggressive leukemia exhibits unique characteristics similar to normal S-100 beta+T lymphocytes.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • T cell leukemia is a significant hematologic malignancy.
  • Suppressor/cytotoxic (s/c) T cell phenotypes are crucial in immune regulation.
  • S-100b protein expression in lymphocytes is a subject of ongoing research.

Observation:

  • A 34-year-old woman presented with splenomegaly and rapid disease progression.
  • Leukemic cells displayed lymphocyte morphology and suppressor/cytotoxic T cell phenotypes.
  • Leukemic cells were positive for S-100b protein and showed T cell receptor (TcR) beta chain gene rearrangement.

Findings:

  • The case was identified as S-100 beta positive T cell leukemia due to identical features with normal S-100 beta+T lymphocytes.
  • Clinicopathological analysis of similar reported cases was performed.

Related Experiment Videos

  • S-100 beta +T cell leukemia/lymphoma is characterized as a novel aggressive subtype of s/c T lymphocytic leukemia/lymphoma.

    • Implications:

    • This finding expands the understanding of T cell leukemia subtypes.
    • Recognition of S-100 beta +T cell leukemia/lymphoma may improve diagnostic accuracy.
    • Further research into the pathogenesis and treatment of this aggressive leukemia is warranted.